title: Inversion time prolongation at late enhancement cardiac MRI in a myeloma patient.
abstract: A patient undergoing chemotherapy for multiple myeloma had a sudden onset of heart failure. Cardiac magnetic resonance was performed after echocardiography to rule out  myocardial late enhancement, which was not detected. In- terestingly, the inversion time of the T1-weighted inversion recovery late enhancement sequence needed to be significantly increased (from the usual 250-300 to 490 ms) to obtain diagnostic images. This report presents the clinical case of this patient, and discusses potential implications.
authors.affiliation: Department of Radiology, Guglielmo da Saliceto Hospital, Piacenza, Italy. belloni.elena@alice.it
authors.forename: Elena
authors.initials: E
authors.lastname: Belloni
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Marchesi
authors.forename: Daniela
authors.initials: D
authors.lastname: Aschieri
authors.forename: Patrizia
authors.initials: P
authors.lastname: Bernuzzi
authors.forename: Elena
authors.initials: E
authors.lastname: Trabacchi
authors.forename: Daniele
authors.initials: D
authors.lastname: Vallisa
authors.forename: Giovanni Quinto
authors.initials: GQ
authors.lastname: Villani
authors.forename: Luigi
authors.initials: L
authors.lastname: Cavanna
authors.forename: Emanuele
authors.initials: E
authors.lastname: Michieletti
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D003287:Contrast Media; D003937:Diagnosis, Differential; D004452:Echocardiography / Q000379:methods; D017809:Fatal Outcome; D006333:Heart Failure / Q000150:complications* / Q000175:diagnosis*; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D007091:Image Processing, Computer-Assisted / Q000379:methods; D000077269:Lenalidomide; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008536:Meglumine; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D009206:Myocardium / Q000473:pathology; D009942:Organometallic Compounds; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D003287:Contrast Media; D009942:Organometallic Compounds; D013792:Thalidomide; D008536:Meglumine; D000077269:Lenalidomide; C072417:gadoterate meglumine